1. Home
  2. CLGN vs VRAR Comparison

CLGN vs VRAR Comparison

Compare CLGN & VRAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CollPlant Biotechnologies Ltd

CLGN

CollPlant Biotechnologies Ltd

N/A

Current Price

$0.71

Market Cap

18.4M

Sector

Health Care

ML Signal

N/A

Logo The Glimpse Group Inc.

VRAR

The Glimpse Group Inc.

N/A

Current Price

$0.74

Market Cap

21.5M

Sector

Technology

ML Signal

N/A

Company Overview

Basic Information
Metric
CLGN
VRAR
Founded
2004
2016
Country
Israel
United States
Employees
N/A
N/A
Industry
Industrial Specialties
Retail: Computer Software & Peripheral Equipment
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
18.4M
21.5M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
CLGN
VRAR
Price
$0.71
$0.74
Analyst Decision
Buy
Strong Buy
Analyst Count
2
1
Target Price
$11.00
$2.62
AVG Volume (30 Days)
114.3K
108.2K
Earning Date
03-25-2026
02-17-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$2,475,000.00
$9,488,209.00
Revenue This Year
$1,596.12
N/A
Revenue Next Year
$85.83
$72.00
P/E Ratio
N/A
N/A
Revenue Growth
280.77
16.60
52 Week Low
$0.59
$0.74
52 Week High
$4.98
$1.87

Technical Indicators

Market Signals
Indicator
CLGN
VRAR
Relative Strength Index (RSI) 28.16 34.02
Support Level $0.66 $0.74
Resistance Level $0.74 $0.83
Average True Range (ATR) 0.14 0.10
MACD -0.09 -0.02
Stochastic Oscillator 8.57 0.33

Price Performance

Historical Comparison
CLGN
VRAR

About CLGN CollPlant Biotechnologies Ltd

CollPlant Biotechnologies Ltd is a regenerative and aesthetic medicine company focused on 3D bioprinting of tissues and organs and medical aesthetics. Its products are based on its rhCollagen (recombinant human collagen) produced with CollPlant's proprietary plant based genetic engineering technology. These products address indications for the diverse fields of tissue repair, aesthetics, and organ manufacturing. The revenues include income from business collaborators and sales of the BioInk product for the development of 3D bioprinting of organs and tissues, sales of rhCollagen for the medical aesthetics market, and sales in Europe of the products for tendinopathy and wound healing. The company operates in United States, which derives key revenue, Canada, Europe and Other, and Israel.

About VRAR The Glimpse Group Inc.

The Glimpse Group Inc is a diversified immersive technology platform company, focused on providing enterprise solutions in virtual reality (VR), augmented reality (AR), and spatial computing. The company operates multiple subsidiaries that develop VR and AR software and services across various industries, including corporate training, education, healthcare, government, defense, marketing, retail, and financial services. It also offers AI-driven spatial computing platforms that support simulations, social VR, behavioral health, and corporate events. The Company reports its revenues in three categories: Software Services, Software License and Software-as-a-Service (SaaS), and Royalty Income, with the majority being from the Software Services category.

Share on Social Networks: